Imidafenacin

Imidafenacin is an antispasmodic agent with anticholinergic effects. It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder. It is marketed in Japan under the tradenames Staybla by Ono Pharmaceutical and Uritos by Kyojin Pharmaceutical. It is grouped under the following drug class(es): Overactive bladder agents. Its therapeutic use is listed as urological agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Uritos, Staybla and imidafenacinum. Its PubChem CID is 6433090.

CAS No 170105-16-5
Molecular Formula C20H21N3O
Molecular Weight 319.4 g/mol
Synonyms 4-(2-methylimidazol-1-yl)-2,2-diphenylbutanamide

Frequently Asked Questions